文献速递肝病

二维剪切波弹性成像评估经活检证实的肝纤维化:基于个体患者数据的Meta分析

Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.
PubMed 文献 · Hepatology · 2017-11-15

该研究基于13个中心1134例同时接受二维剪切波弹性成像(2D-SWE)与肝活检的患者数据,评估2D-SWE对肝纤维化的诊断效能。丙型肝炎、乙型肝炎和非酒精性脂肪性肝病患者中,诊断显著纤维化的AUROC分别为86.3%、90.6%和85.5%,诊断肝硬化的AUROC分别为92.9%、95.5%和91.7%。2D-SWE诊断显著纤维化和肝硬化的AUROC均高于瞬时弹性成像。

要点

  • 2D-SWE诊断乙型肝炎患者显著纤维化和肝硬化的AUROC分别为90.6%和95.5%。
  • 2D-SWE诊断显著纤维化的AUROC比瞬时弹性成像高0.022-0.084(95%CI,P=0.001)。
  • 2D-SWE诊断肝硬化的AUROC比瞬时弹性成像高0.003-0.034(95%CI,P=0.022)。

核心结论

  • 2D-SWE对乙型肝炎患者的肝纤维化无创分期具有良好至优秀的诊断效能。
  • 需要进一步的前瞻性研究对2D-SWE与其他影像学方法进行头对头比较,以建立针对不同疾病的合适肝纤维化分期截断值。

研究设计与样本

  • 基于个体患者数据的Meta分析,联系使用Aixplorer超声设备的中心共享数据。
  • 采用随机效应模型的直接法和配对受试者工作特征曲线及曲线下面积(AUROC)分析。
  • 共纳入来自13个中心的1134例同时具有2D-SWE和肝活检数据的患者,其中665例有成功的瞬时弹性成像数据。
  • 多数患者为慢性丙型肝炎(n=379)、乙型肝炎(n=400)或非酒精性脂肪性肝病(n=156)。

主要发现

  • 丙型肝炎、乙型肝炎和非酒精性脂肪性肝病患者中,2D-SWE诊断显著纤维化的AUROC分别为86.3%、90.6%和85.5%。
  • 丙型肝炎、乙型肝炎和非酒精性脂肪性肝病患者中,2D-SWE诊断肝硬化的AUROC分别为92.9%、95.5%和91.7%。
  • 在所有患者中,2D-SWE诊断显著纤维化的AUROC比瞬时弹性成像高0.022-0.084(95%CI,P=0.001)。
  • 在所有患者中,2D-SWE诊断肝硬化的AUROC比瞬时弹性成像高0.003-0.034(95%CI,P=0.022)。
  • 这一差异在乙型肝炎患者中最为明显。

关键数值与推荐

  • 诊断显著纤维化:丙型肝炎患者2D-SWE的AUROC为86.3%,乙型肝炎为90.6%,非酒精性脂肪性肝病为85.5%。
  • 诊断肝硬化:丙型肝炎患者2D-SWE的AUROC为92.9%,乙型肝炎为95.5%,非酒精性脂肪性肝病为91.7%。
  • 2D-SWE与瞬时弹性成像诊断显著纤维化的AUROC差值:0.022-0.084(95%CI,P=0.001)。
  • 2D-SWE与瞬时弹性成像诊断肝硬化的AUROC差值:0.003-0.034(95%CI,P=0.022)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步的前瞻性研究对2D-SWE与其他影像学方法进行头对头比较,以建立针对不同疾病的合适肝纤维化分期截断值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Two-dimensional shear wave elastography (2D-SWE) has proven to be efficient for the evaluation of liver fibrosis in small to moderate-sized clinical trials. We aimed at running a larger-scale meta-analysis of individual data. Centers which have worked with Aixplorer ultrasound equipment were contacted to share their data. Retrospective statistical analysis used direct and paired receiver operating characteristic and area under the receiver operating characteristic curve (AUROC) analyses, accounting for random effects. Data on both 2D-SWE and liver biopsy were available for 1,134 patients from 13 sites, as well as on successful transient elastography in 665 patients. Most patients had chronic hepatitis C (n = 379), hepatitis B (n = 400), or nonalcoholic fatty liver disease (n = 156). AUROCs of 2D-SWE in patients with hepatitis C, hepatitis B, and nonalcoholic fatty liver disease were 86.3%, 90.6%, and 85.5% for diagnosing significant fibrosis and 92.9%, 95.5%, and 91.7% for diagnosing cirrhosis, respectively. The AUROC of 2D-SWE was 0.022-0.084 (95% confidence interval) larger than the AUROC of transient elastography for diagnosing significant fibrosis (P = 0.001) and 0.003-0.034 for diagnosing cirrhosis (P = 0.022) in all patients. This difference was strongest in hepatitis B patients. CONCLUSION: 2D-SWE has good to excellent performance for the noninvasive staging of liver fibrosis in patients with hepatitis B; further prospective studies are needed for head-to-head comparison between 2D-SWE and other imaging modalities to establish disease-specific appropriate cutoff points for assessment of fibrosis stage. (Hepatology 2018;67:260-272).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Herrmann E, de Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. Hepatology. 2017. PMID: 28370257. doi:10.1002/hep.29179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。